Slide 1 — Title and key message Time: 30 seconds Title: The 150-day clinical trial set-up target: implications for research delivery teams Open with: “The 150-day target is designed to move clinical trials from regulatory submission to recruiting the first participant more quickly, while maintaining quality, safety and regulatory compliance.” Slide 2 — What is the 150-day target? Time: 1 minute Show the timeline visually: Regulatory submission → Approval → Site opening → First participant recruited 60 days: combined regulatory review. 60 days: approval to site opening. 30 days: site opening to first participant recruited. Total: 150 days. Key point: Successful set-up does not end when approvals are received. It ends when the study is operational and has recruited its first participant. Slide 3 — Why does it matter? Time: 1 minute Cover the main reasons: Earlier access to research for patients. Greater predictability for sponsors and funders. Improved UK competitiveness for commercial research. Less duplication and unnecessary delay. Better use of NHS research capacity and resources. Key message: The target creates shared accountability across regulators, sponsors, R&D teams, investigators and research delivery teams.
Slide 1 — Title and key message
Time: 30 seconds
Title:
The 150-day clinical trial set-up target: implications for research delivery teams
Open with:
“The 150-day target is designed to move clinical trials from regulatory submission to recruiting the first participant more quickly, while maintaining quality, safety and regulatory compliance.”
Slide 2 — What is the 150-day target?
Time: 1 minute
Show the timeline visually:
Regulatory submission → Approval → Site opening → First participant recruited
60 days: combined regulatory review.
60 days: approval to site opening.
30 days: site opening to first participant recruited.
Total: 150 days.
Key point:
Successful set-up does not end when approvals are received. It ends when the study is operational and has recruited its first participant.
Slide 3 — Why does it matter?
Time: 1 minute
Cover the main reasons:
Earlier access to research for patients.
Greater predictability for sponsors and funders.
Improved UK competitiveness for commercial research.
Less duplication and unnecessary delay.
Better use of NHS research capacity and resources.
Key message:
The target creates shared accountability across regulators, sponsors, R&D teams, investigators and research delivery teams.
Created using ChatSlide
This 10-minute presentation outlines the key aspects of the 150-day clinical trial set-up target and its importance for research delivery teams. The target aims to expedite clinical trials from regulatory submission to the recruitment of the first participant while ensuring quality and compliance. It offers earlier patient access to research, predictability for sponsors, enhances UK competitiveness, and optimises NHS resources. Research teams must engage earlier in feasibility studies and...